RECORD-2: Phase II randomized study of everolimus and bevacizumab versus interferon α-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma
Journal
Annals of Oncology
Journal Volume
26
Journal Issue
7
Pages
1378-1384
Date Issued
2015
Author(s)
Ravaud A.
Barrios C.H.
Alekseev B.
Tay M.-H.
Agarwala S.S.
Yalcin S.
Roman L.
Shkolnik M.
Anak O.
Gogov S.
Pelov D.
Louveau A.-L.
Melichar B.
Publisher
Oxford University Press
Type
journal article